Metabolic effects of Diabecinn (oral cinnamon extract) in diabetes type 2, a placebo-controlled randomized clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28157

Enrollment

120

Registered

2006-03-21

Start date

2006-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Diabecinn tid or placebo.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes patients; 2. Age 35-70 years inclusive; 3. HbA1c between 7 and 12% inclusive.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Breast-feeding.

Design outcomes

Primary

Measure	Time frame
HbA1c.	—

Secondary

Measure	Time frame
1. Lipid profile; 2. 6 point glucose profile; 3. Hypoglycemia; 4. Body weight; 5. Free fatty acids; 6. CRP.	—

Contacts

Public ContactJ.H. DeVries

Academic Medical Center, Department of Internal Medicine, F4-222, P.O. Box 22660

j.h.devries@amc.uva.nl+31 (0)20 5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)